首页 >
法规速递
-
Document: PRAC recommendations on signals adopted at the 12-15 January 2026 PRAC meeting-2026/2/9
2026-02-10查看详情 > -
Page: Quality Innovation Group-2026/3/18
2026-03-19查看详情 > -
Document: Process for submitting existing data on medicinal products authorised for human use – SIAMED II & XEVMPD to PMS deltas - Chapter 9-2026/4/21
2026-04-22查看详情 > -
国家药监局药审中心关于发布《药物真实世界研究设计与方案框架指导原则（试行）》的通告（2023年第5号）-2023/02/16
2023-02-16查看详情 > -
国家药监局综合司公开征求《药品网络交易第三方平台检查指导原则（征求意见稿）》意见-2023/9/6
2023-09-07查看详情 > -
Interim Policy on Compounding Using Bulk Drug Substances Under Section 503A of the Federal Food, Drug, and Cosmetic Act-2025/1/6
2025-01-07查看详情 > -
Document: EMA human resources strategy: Priorities 2023-2025-2025/2/6
2025-02-10查看详情 > -
Document: Agenda - Management Board meeting: 13 March 2025-2025/3/14
2025-03-17查看详情 > -
Document: Substances considered as not falling within the scope of Regulation (EC) No. 470/2009, with regard to residues of veterinary medicinal products in foodstuffs of animal origin-2025/4/16
2025-04-16查看详情 > -
Document: Process for the electronic submission of medicinal product information - Chapter 3-2025/6/2
2025-06-03查看详情 >
